Chromatography media and method
View Patent ↗Adsorptive media for chromatography, particularly ion-exchange chromatography, derived from a shaped fiber. In certain embodiments, the functionalized shaped fiber presents a fibrillated or ridged structure which greatly increases the surface area of the fibers when compared to ordinary fibers. Also disclosed herein is a method to add surface pendant functional groups that provides cation-exchange or anion-exchange functionality to the high surface area fibers. This pendant functionality is useful for the ion-exchange chromatographic purification of biomolecules, such as monoclonal antibodies (mAbs).
1. A process for purifying a sample comprising a biomolecule, comprising contacting said sample with a bed of fiber media, said fibers having a cross-section comprising a body region defining a substantially longitudinal axis, and having a plurality of projections extending outwardly from said body region, said fibers having imparted thereon functionality enabling ion-exchange chromatography.
2. The process of claim 1 , wherein said bed of fiber media is an axially compressed bed of cut nylon staple fiber media, and wherein said functionality is anion exchange functionality that enables purification in a flow through mode.
3. The process of claim 1 , wherein said functionality enables purification in a bind/elute mode.
4. A process of purifying a sample comprising a biomolecule of interest and impurities, comprising:
providing a sample comprising the biomolecule of interest and impurities;
contacting said sample with a chromatography media comprising an axially compressed bed of cut nylon staple fibers, said fibers having a cross-section comprising a region comprising a body region defining a substantially longitudinal axis, and a plurality of projections extending outwardly from said body region, said fibers having imparted thereon anion-exchange functionality, acrylic polymer functionality or cation-exchange functionality thereby to bind the biomolecule of interest or impurities; and
recovering the biomolecule of interest.
5. The process of claim 4 , wherein the biomolecule of interest is bound to the chromatography media, and is recovered by elution.
6. The process of claim 4 , wherein the impurities are bound to the chromatography media, and the biomolecule of interest is recovered in a flow-through mode.
7. The process of claim 1 , wherein said biomolecule comprises a monoclonal antibody.
8. A process for purifying a negatively-charged virus, comprising providing a sample containing negatively-charged virus; contacting said sample containing said negatively-charged virus with an axially compressed bed of cut nylon staple fiber media, wherein said cut fibers have a cross-section comprising a body region defining a substantially longitudinal axis, and have a plurality of projections extending outwardly from said body region, and wherein said fibers have imparted thereon a polymeric functionality, wherein the surfaces of said polymeric functionality are modified with pendant trimethylammonium groups; washing said fibers to remove unbound species; and eluting said negatively-charged virus, thereby to purify the negatively-charged virus; wherein said negatively charged virus is bacteriophage ø6.
9. A process for removing a negatively-charged virus from a sample, comprising providing a sample containing negatively-charged virus; contacting said sample containing said negatively-charged virus with an axially compressed bed of cut nylon staple fiber media, wherein said cut fibers have a cross-section comprising a body region defining a substantially longitudinal axis, and have a plurality of projections extending outwardly from said body region, said fibers having imparted thereon a polymeric functionality, wherein the surfaces of said polymeric functionality are modified with pendant trimethylammonium groups, thereby binding said negative-charged virus to said fibers, washing said fibers to remove unbound species; and eluting said negatively-charged virus; wherein said negatively charged virus is bacteriophage ø6.
10. The process of claim 1 , wherein said fibers are packed in a container at a density of between 0.1 and 0.5 g/ml and are randomly oriented.
11. The process of claim 4 , wherein said fibers are packed in a container at a density of between 0.1 and 0.5 g/ml and are randomly oriented.
12. The process of claim 8 , wherein said fibers are packed in a container at a density of between 0.1 and 0.5 g/ml and are randomly oriented.
13. The process of claim 9 , wherein said fibers are packed in a container at a density of between 0.1 and 0.5 g/ml and are randomly oriented.
14. The process of claim 8 , wherein said fibers are epoxy-functionalized fibers modified with trimethylamine.
15. The process of claim 9 , wherein said fibers are epoxy-functionalized fibers modified with trimethylamine.